What’s Behind CRA International (CRAI) Stock’s Latest Move?
CRA International (CRAI) is in focus after reporting second quarter results that exceeded analyst expectations, along with broad-based growth in key consulting practices that accounted for more than 95% of total revenue.
See our latest analysis for CRA International.
The latest results and refinancing news come after a mixed share price run for CRA International, with the stock down 18.11% on a year to date share price basis but still showing a 59.37% three year total shareholder return. This suggests that longer term holders have yet to see recent weakness erase earlier gains.
If you are reviewing CRA International alongside other ideas, it may be a good time to widen your search and see 21 top founder-led companies
After a sharp year-to-date pullback and a strong three-year return, CRA International now sits at an interesting crossroads. Does the current valuation already reflect that mixed picture, or are investors being compensated to wait for a better entry point?
Most Popular Narrative: 35% Undervalued
Compared with the most followed valuation narrative, CRA International's last close of $164.21 sits well below an implied fair value of $252.50. That gap is built on a detailed set of growth, margin and capital allocation assumptions that go beyond the latest quarter.
The surge in global regulatory complexity and heightened enforcement, especially in antitrust, is driving robust and sustained demand for CRA's advisory services, as evidenced by record performance in their Antitrust & Competition Economics practice, this is likely to support higher long-term revenue growth.
Curious what kind of revenue profile, margin lift and future earnings multiple are embedded in that valuation gap? The narrative sets a clear growth path and a richer future P/E, underpinned by specific assumptions on profitability and share count that are worth seeing in full.
Result: Fair Value of $252.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, CRA International’s reliance on robust M&A and antitrust work, combined with ongoing share buybacks and net debt, could quickly challenge that undervaluation narrative if conditions shift.
Find out about the key risks to this CRA International narrative.
Another View On CRA International’s Valuation
The earlier narrative focuses on CRA International appearing 35% undervalued based on future earnings assumptions and a higher future P/E. At present, however, the stock trades on a P/E of 21x, compared with a fair ratio of 16.8x and a peer average of 28.9x.
This combination, being cheaper than peers but more expensive than the fair ratio, highlights both potential upside and clear re-rating risk if expectations cool. Which side of that trade off you emphasize will depend on your own investment timeframe.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
This mix of opportunity and concern around CRA International will mean different things to different investors, so it makes sense to move quickly and review the underlying data yourself. To gauge both sides in one place, start with the 2 key rewards and 3 important warning signs
Looking for more investment ideas beyond CRA International?
If CRA International has caught your eye, do not stop there. Use the Simply Wall St screener to quickly surface other stocks that might fit your approach.
- Target potential value opportunities by scanning for companies that look attractively priced relative to fundamentals using the 53 high quality undervalued stocks.
- Strengthen your focus on stability by reviewing companies highlighted in the 80 resilient stocks with low risk scores.
- Get ahead of the crowd by checking the screener containing 19 high quality undiscovered gems before the market pays closer attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com